英文名称 |
中文名称 |
CAS |
Olanzapine Impurity 25
|
ADP-BEJ-P1 |
52833-34-8 |
Mirabegron impurity 003
|
米拉贝隆标准品003 |
1018983-85-1 |
Vonoprazan Impurity 24
|
沃诺拉赞杂质35 |
1883595-39-8 |
Linezolid Impurity 42
|
2-氨基-3-氯丙烷-1-羟基 |
725676-93-7 |
Rosuvastatin Impurity 12
|
瑞舒伐他汀酸水解未完全产物 |
894787-93-0 |
Olmesartan Impurity 13
|
奥美沙坦酯标准品013 |
138402-33-2 |
Sodium 2-((2S,5S)-5-benzyl-3,6-dioxopiperazin-2-yl)acetate
|
鲁拉西酮标准品-NA |
136983-81-8 |
2-Chloro Vonoprazan
|
文诺普兰杂质 |
928325-68-2 |
Linezolid Impurity 44
|
利奈唑胺杂质10 |
183805-10-9 |
Mirabegron impurity 002
|
米拉贝隆标准品002 |
81259-56-5 |
1-Methyl-4-sulfopyridinium Hydroxide Inner Salt
|
文诺普兰杂质 |
4416-69-7 |
p-[N-(p-Fluorophenyl)formimidoyl]phenol
|
4-{[(4-氟苯基)亚胺基]甲基}苯酚 |
3382-63-6 |
Febuxostat Impurity 23
|
非布索坦杂质39 |
2073891-59-3 |
Tetrabutylammonium periodate
|
四丁基高碘酸铵 |
65201-77-6 |
Pendimethalin
|
二甲戊灵 |
40487-42-1 |
Cefazolin Impurity D
|
头孢唑啉杂质D |
32510-61-5 |
endo-BCN-PEG4-NHS ester
|
ENDO BCN-PEG4-NHS ESTE |
1807501-86-5 |
Celecoxib Related Compound B
|
塞来昔布相关物质B |
331943-04-5 |
Resiquimod-[d5]
|
Resiquimod D5 |
2252319-44-9 |
Celecoxib Impurity A
|
塞来昔布杂质A |
170570-01-1 |
Rifamycin S
|
利福霉素S |
13553-79-2 |
PF-04457845
|
N-哒嗪-3-基-4-(3-{[5-(三氟甲基)吡啶-2-基]醚}苯亚甲基丙酮)哌啶-1-羧酰胺 |
1020315-31-4 |
Proteinase K
|
蛋白酶K |
39450-01-6 |
GYY-4137 Morpholine salt
|
(4-甲氧基苯基)吗啉基-二硫代膦酸与吗啉的化合物 |
106740-09-4 |
6-Ethynyl-4,4-Dimethyl Thiochroman
|
6-乙炔基-4,4-二甲基二氢苯并噻喃 |
118292-06-1 |
N'-(5-Chloropyridin-2-yl)-N-[(1R,2R,4R)-4-(dimethylcarbamoyl)-2-[(5-methyl-6,7-dihydro-4H-[1,3]thiazolo[5,4-c]pyridine-2-carbonyl)amino]cyclohexyl]oxamide
|
依度沙班杂质RRR |
1255529-24-8 |
Cefazolin EP Impurity G
|
头孢唑啉钠杂质G |
1172998-53-6 |
Atorvastatin EP Impurity C
|
阿托伐他汀钙杂质C |
693793-53-2 |
1-methylpyridin-1-ium-2-carboxamide iodide
|
氯解磷定标准品3-I |
3861-69-6 |
Terazosin EP Impurity E
|
特拉唑嗪杂质E |
102839-00-9 |
1-methylpyridin-1-ium-2-carboxamide chloride
|
氯解磷定标准品-CL |
21032-31-5 |
6,7-dimethoxy-2-piperazin-1-ylquinazolin-4-amine hydrochloride
|
特拉唑嗪杂质 |
70843-11-7 |
Terazosin Related Compound A
|
特拉唑嗪杂质 |
60548-08-5 |
Dapoxetine Impurity 1
|
达泊西汀杂质 |
94305-25-6 |
3-(4-(3-hydroxy-3-phenylpropoxy)naphthalen-1-yl)-1-phenylpropan-1-one
|
达泊西汀杂质 |
2242008-36-0 |
Nifuratel Impurity 6
|
3-氨基-5-[(甲基硫代)甲基]噁唑啉-2-酮 |
25517-72-0 |
(R)-Terazosin
|
盐酸特拉唑嗪 |
109351-34-0 |
Nifuratel Impurity 4
|
硝呋太尔杂质6 |
41359-15-3 |
Terbutaline Impurity 6 hydrobromide
|
特布他林杂质8 |
28924-20-1 |
Dapoxetine Impurity 2
|
达泊西汀杂质 |
2242008-37-1 |
1-(1-phenylethyl)imidazole
|
依托咪酯标准品002 |
60197-34-4 |
Dapoxetine Impurity 8
|
达泊西汀标准品004 |
2245197-07-1 |
Palbociclib Impurity 10
|
帕布昔利布标准品012 |
2206135-30-8 |
Palbociclib Impurity 2
|
帕博西尼杂质G |
2204863-06-7 |
Palbociclib Impurity 022
|
帕布昔利布杂质E |
1779124-68-3 |
Palbociclib Impurity 025
|
帕布昔利布标准品025 |
2174002-16-3 |
Palbociclib Impurity F
|
哌泊塞克雷布杂质F |
1023594-49-1 |
tert-butyl 4-(6-((8-cyclopentyl-5-methyl-7-oxo-6-vinyl-7,8-dihydropyrido[2,3-d]pyrimidin-2-yl)amino)pyridin-3-yl)piperazine-1-carboxylate
|
帕布昔利布杂质 |
1941177-45-2 |
Valdecoxib Impurity I
|
3-[4-[4-(氨基磺酰基)苯基]-5-甲基-3-异恶唑基]苯磺酰胺 |
1373038-59-5 |
N-((4-(5-Methyl-3-phenylisoxazol-4-yl)phenyl)sulfonyl)acetamide
|
帕瑞昔布钠杂质18 |
198471-06-6 |
Valdecoxib Impurity B
|
戊地昔布杂质B |
1373038-60-8 |
Palbociclib Impurity 030
|
Palbociclib-030 |
1211541-02-4 |
Parecoxib Impurity 1
|
帕瑞昔布杂质H |
1708094-99-8 |
methyl 1-(2-chloroacetyl)-2-oxo-3H-indole-6-carboxylate
|
1-(2-氯乙酰基)-2-氧代吲哚啉-6-羧酸甲酯 |
1160293-25-3 |
Palbociclib Impurity 029
|
哌柏西利杂质 |
1566082-34-5 |
Lisinopril Impurity F
|
赖诺普利杂质F |
1132650-67-9 |
Terazosin EP Impurity O
|
特拉唑嗪EP杂质O |
547730-06-3 |
1-Piperazinyl[(2R)-tetrahydro-2-furanyl]methanone
|
盐酸特拉唑嗪 |
412334-56-6 |
Dapoxetine Impurity 2 hydrochloride
|
达泊西汀杂质 |
2242008-38-2 |
Terbutaline Impurity 22
|
特布他林杂质 |
1226543-90-3 |
Esmolol Impurity 1
|
盐酸艾司洛尔杂质4 |
81147-94-6 |
3-(4-hydroxynaphthalen-1-yl)-1-phenylpropan-1-one
|
达泊西汀杂质 |
126113-24-4 |
Etomidate Impurity 1
|
依托咪酯杂质1 |
844658-92-0 |
2-(benzyl(tert-butyl)amino)-1-(3,5-bis(benzyloxy)phenyl)ethan-1-one sulfate
|
特布他林杂质 |
882066-15-1 |
N-Tert-Butyldibenzylamine
|
N,N-二苄基叔丁胺 |
30923-82-1 |
Nifuratel Impurity 2
|
硝呋太尔杂质4 |
1445990-09-9 |
Dapoxetine Impurity 24
|
达泊西汀 |
908291-72-5 |
tert-butyl 4-(4-amino-6,7-dimethoxyquinazolin-2-yl)piperazine-1-carboxylate
|
特拉唑嗪杂质 |
1260939-66-9 |
Dabigatran Impurity 20
|
达比加群酯标准品007 |
1408238-39-0 |
Paroxetine Mesylate
|
甲磺酸帕罗西汀 |
217797-14-3 |
(2S)-Isopropyl 2-(((perfluorophenoxy)(phenoxy)phosphoryl)amino)propanoate
|
索非布韦中间体 |
1256490-52-4 |
Valdecoxib Impurity E
|
戊地昔布杂质E |
1373038-63-1 |
Hydroxy Ivabradine
|
羟基伊伐布雷定 |
1235547-07-5 |
3-(4-Methylphenyl)-5-(trifluoromethyl)-1H-pyrazole
|
3-(4-甲基苯基)-5-三氟甲基吡唑 |
219986-64-8 |
Parecoxib Impurity 24
|
帕瑞昔布杂质 |
198470-82-5 |
Leucosceptoside A
|
米团花苷A |
83529-62-8 |
Dacarbazine
|
达卡巴嗪 |
4342-03-4 |
19-Hydroxy-10-deacetyl baccatin-III
|
卡巴他赛杂质30 |
154083-99-5 |
Fomesafen
|
氟磺胺草醚 |
72178-02-0 |
Deoxyandrographolide
|
去氧穿心莲内酯 |
79233-15-1 |
Mogrol
|
罗汉果醇 |
88930-15-8 |
Nα,Nα-Bis-Fmoc-L-cystine bis(tert-butyl ester)
|
(FMOC-CYS-OTBU)2 |
139592-37-3 |
Ethyl 2-bromothiophene-3-carboxylate
|
2-溴噻吩-3-羧酸乙酯 |
632325-50-9 |
Posaconazole Diastereoisomer Related Compound 2
|
泊沙康唑非对映异构体中间体2 |
166583-12-6 |
15(S)-Latanoprost
|
15(S)-拉坦前列素 |
145773-22-4 |
Pantoprazole EP Impurity E
|
泮托拉唑杂质E |
2115779-15-0 |
Triethylene Glycol Mono(2-propynyl) Ether
|
丙炔基-三聚乙二醇 |
208827-90-1 |
Chrysin-7-O-glucoronide
|
白杨素-7-0-Β-D-葡萄糖醛酸苷 |
35775-49-6 |
Monodes(N-carboxymethyl)valine Daclatasvir
|
达卡它韦杂质 |
1007884-60-7 |
DOTA-NOC
|
DOTA-NOC |
619300-53-7 |
Ethyl 5-bromothieno[3,2-b]thiophene-6-carboxylate
|
ETHYL 2-BROMOTHIENO[3,2-B]THIOPHENE-3-CARBOXYLATE |
2055722-78-4 |
Dapagliflozin Impurity 3
|
达格列净杂质 |
1807632-95-6 |
Ingenol-5,20-acetonide
|
巨大戟醇-5,20-缩丙酮 |
77573-43-4 |
MCP110
|
化合物 T24437 |
521310-51-0 |
(3R,5R)-Rosuvastatin Calcium
|
瑞舒伐他汀钙杂质B02 |
1422515-55-6 |
Heptakis(6-deoxy-6-thio)-beta-cyclodextrin
|
全巯基-倍他-环糊精 |
160661-60-9 |
Cy5-NHS ester
|
CY5-NHS酯 |
146368-14-1 |
Semax
|
脑力肽 |
80714-61-0 |
(3S,5R)-Rosuvastatin
|
(3S,5R)-瑞舒伐他汀 |
1242184-42-4 |
Polyadenosinic acid potassium salt
|
多聚腺苷酸钾盐,POLY(A)钾盐 |
26763-19-9 |